Canaccord Genuity Initiates Coverage of Afentra (STGAF) with Buy Recommendation
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Sep 21 2024
0mins
Should l Buy ?
Source: NASDAQ.COM
Analyst Coverage and Price Target: Canaccord Genuity has initiated coverage of Afentra with a Buy recommendation, but the average one-year price target suggests a 34.54% downside from its current price of $0.67/share, forecasting a target of $0.44/share.
Fund Sentiment and Ownership: There is minimal institutional interest in Afentra, with only one fund holding 103K shares, representing 0.05% ownership, and no changes in positions over the last quarter.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
